Charleston, SC -- (SBWIRE) -- 08/29/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: NanoViricides Inc (OTCBB:NNVC), Safecode Drug Technologies Corp (OTCBB:SAFC), Affymax, Inc. (OTCMKTS:AFFY), Federal Home Loan Mortgage Corp (OTCBB:FMCC)
NanoViricides Inc (OTCBB:NNVC) remained a bear for the day as it reported the loss of -2.54% and closed at $1.15 after gaining total volume of 60,300 shares. Its introductory price for the day was $1.18. So far, the company’s stock is up +143.13% in the three months period. In the last 6 months of trade it reported a decline of +139.58%.
NanoViricides, Inc., a nano-biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of viral infections.
Has NNVC Found The Bottom And Ready To Gain Momentum? Find Out Here
Safecode Drug Technologies Corp (OTCBB:SAFC) reported the decline of -23.08% and closed at $ 0.0020 with the total traded volume of 21.64 million shares. The stock's opening price was $ 0.0021. The company has a total market capitalization of $ 286,749.
The 52-week price range of the stock remained $0.0015 - $0.335, while during last trade its minimum price was $0.0015 and it gained its highest price of $0.0025. Company's last 5 days shows a down turn with a decline of -33.33%. SafeCode Drug Technologies Corp., a development stage company, focuses on patenting and developing a commercial application of a voice enabled protector for administering medicine.
Why Should Investors Buy SAFC After the Recent Fall? Just Go Here and Find Out
Affymax, Inc. (OTCMKTS:AFFY) ended its day with the declining stream with the plunge of -15.24% and closed at the price of $1.57 after opening at $1.85. Stock traded during its last trading session with the total volume of 3.87 million shares, as compared to its average volume of 1.28 million shares.
During the previous session, the company’s minimum price was $1.53, while it touched its highest price for the day at $1.95. AFFY’s beta value stands at 1.46 points. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Will AFFY Get Buyers Even After The Recent Rally? Find Out Here
Federal Home Loan Mortgage Corp (OTCBB:FMCC) reported the gain of +2.68%, to close at $1.15, with the overall traded volume of 2.54 million shares.
So far, in the past three months, the stock is down -69.33%. The 52-week range for the stock is $0.23 and $5.00 and during the previous trading session the stock touched its highest price at $1.16. Its introductory price for the day was $1.12. Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States.
For How Long FMCC will Fight for Profitability? Read This Trend Analysis report
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)